neochamaejasmin A

cytotoxic compound from the roots of a traditional Chinese medicine, Stellera chamaejasme L.; inhibits human prostate LNCaP cancer cells; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Chen, Xiaoyu: 1 article (01/2020)
2.	Ding, Yangfang: 1 article (01/2020)
3.	Fan, Xinmei: 1 article (01/2020)
4.	Li, Defang: 1 article (01/2020)
5.	Li, Mingkai: 1 article (01/2020)
6.	Liu, Wenjing: 1 article (01/2020)
7.	Pan, Zhaohai: 1 article (01/2020)
8.	Xie, Qi: 1 article (01/2020)
9.	Zhao, Wei: 1 article (01/2020)
10.	Zheng, Qiusheng: 1 article (01/2020)

Related Diseases

1.	Prostatic Neoplasms (Prostate Cancer) 05/01/2008 - "Neochamaejasmin A ( 1), a biflavonoid isolated from the roots of a traditional Chinese medicine, Stellera chamaejasme L., was shown to inhibit cellular (3)H-thymidine incorporation (IC 50 12.5 microg/mL) and subsequent proliferation of human prostate cancer LNCaP cells. "
2.	Neoplasms (Cancer) 05/01/2008 - "Involvement of p21 and FasL in induction of cell cycle arrest and apoptosis by neochamaejasmin A in human prostate LNCaP cancer cells."
3.	Hepatocellular Carcinoma (Hepatoma) 01/01/2020 - "Neochamaejasmin A Induces Mitochondrial-Mediated Apoptosis in Human Hepatoma Cells via ROS-Dependent Activation of the ERK1/2/JNK Signaling Pathway."

Related Drugs and Biologics

1.	Biflavonoids

Related Therapies and Procedures

1.	Chinese Traditional Medicine (Traditional Chinese Medicine)